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ABSTRACT 
 
The way that a diagnosis of dementia is delivered to patients, what information is provided and what 
practical advice and support is arranged will have a lasting impact and deserves at least as much 
attention as the process of assessment and investigation. An honest yet sensitive discussion about the 
nature and cause of the problems is needed, using non-technical language and tailored to the 
priorities and needs of the individual and their family. This should lead on to provision of good 
quality information in an accessible format. Interventions to prioritise will include medication 
review, attention to sensory deficits,  appropriate pharmacological and nonpharmacological 
treatment, best use of memory aids and strategies, and driving, financial entitlement and legal advice. 
Referral onwards should be made to an appropriate individual or service who will be able to provide 
ongoing emotional and practical support and signposting. 
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INTRODUCTION 
 
Receiving a timely diagnosis of dementia and its subtype can have many benefits, but it also presents 
many challenges.1 Confirmation that changes in cognitive ability and day to day functioning have a 
medical cause and giving a name to it is often a relief, providing an explanation for the difficulties 
being experienced and reducing anxiety of both the person with dementia and their families and 
carers.2 3  However, a positive outcome will depend on the communication skills of the clinician to 
deliver a good understanding of the diagnosis and its implications. They should also take 
responsibility for arranging what happens next.  
 
Unfortunately, disclosure of dementia diagnosis is sometimes poorly handled and post-diagnostic 
support is too often inadequate.4  Some clinicians are reluctant to provide a precise diagnosis or to 
explain prognosis and some avoid using the ‘D’ or ‘A’ word, clouding the truth by using 
euphemisms such as age-related changes or problems with the blood supply, or hiding behind 
technical terminology such as hippocampal atrophy or neurocognitive disorder. Too often the time 
spent in explanation is inadequate and people still report that information was given in an abrupt or 
insensitive manner. By contrast, a clear and sensitive discussion about diagnosis, tailored to the stage 
of the condition and the priorities and needs of the person with dementia and those caring for them, 
should lead on to considering practical interventions allowing all involved to ‘live well with 
dementia’.5 6  
 
TELLING THE DIAGNOSIS 
 
All people with dementia have the right to know their diagnosis and most will wish to be fully 
informed.7 Disclosing diagnosis to the family only or allowing them to refuse the person with 
dementia being told is rarely justifiable. Rather, the person with dementia must be given the 
opportunity to learn as much or as little as they want to know. It is not for professionals (or family, 
or carers) to decide, but to respond by providing information with empathy and understanding. Those 
affected by anosognosia who may be unaware of their cognitive deficits need to be handled with 
particular care in order to avoid an argumentative or angry reaction.  
With patient consent, telling the diagnosis should ordinarily occur in a joint meeting with family. As 
with any difficult consultation it will go best when structured, for example using the SPIKES six step 
protocol for delivering bad news (Table 1).8   
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Table 1. Six-step SPIKES model for delivering bad news 8 
S - SETTING UP 
• Review the plan for giving the diagnosis  
• Ensure environment appropriate and no distractions 
• Involve significant others 
• Establish rapport 
• Manage time constraints and ensure no interruptions 
 
P - PERCEPTION 
• Explore people’s knowledge, what they suspect, and hopes 
• Consider level of understanding and retention 
• Establish any lack of insight, denial or unrealistic expectations 
 
I – INVITATION or INFORMATION 
• Establish what information is wanted 
• Accept people’s right not to know 
• Offer to answer any questions later if wanted 
• Ask if happy to share information with relatives or friends 
  
K – KNOWLEDGE 
• Give warning shot that bad news is coming 
• Match explanation to level of comprehension 
• Use non-technical language 
• Deliver information in small chunks 
• Periodically check understanding of what has been said 
• Get to the point but avoid unnecessary bluntness 
• Don’t be relentlessly negative - highlight strengths as well as weaknesses 
 
E – EMPATHY 
• Anticipate and recognise people’s fears and concerns 
• Identify the reason for the emotion 
• Be supportive by combining empathic, exploratory and validating responses 
• Be mindful of your own emotional response 
 
S – STRATEGISE and SUMMARISE 
• Ask if people want anything clarified 
• Acknowledge and answer questions 
• Understand important specific goals that people may have 
• Explain available support and negotiate management plan  
• Summarise and agree follow up 
• Be realistic but try to end by highlighting the positives 
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Sufficient time must be available to explain complexities in a manner accessible to both the person 
with dementia and those accompanying them.9 The presence of cognitive impairment means there 
will be a greater need than usual to repeat information and to check its understanding, rephrasing as 
necessary. It is helpful to write down the important points so that they can be re-read as often as 
required and be taken away after the consultation. 
It is important to use both the term dementia and its subtype explicitly due to differences in disease 
course and management. Given the growing public awareness of Alzheimer’s disease, this diagnosis 
may not come as a surprise but misconceptions and misunderstandings about terminology will still 
need to be cleared up, most commonly the difference between dementia and Alzheimer’s disease. 
Use of the term probable Alzheimer’s disease is best avoided as it raises the spectre of diagnostic 
uncertainty and may frustrate and confuse people. Less common conditions such as Lewy body and 
frontotemporal dementias will need fuller explanation and terms such as primary progressive aphasia 
and posterior cortical atrophy are best described as particular presentations of subtypes of dementia, 
rather than specific medical conditions. Given that the consequences of stroke are widely perceived 
in terms of physical function, it may be necessary to emphasise that a vascular dementia is a 
consequence of a past stroke rather than a new medical condition. Similarly, unless clarified, many 
people’s previous understanding of Parkinson’s disease as solely a movement disorder may suggest 
to them that dementia is a second diagnosis, or raise concern about previous misdiagnosis.  
Accurately predicting the rate of decline of dementia is challenging. Nevertheless, telling a diagnosis 
without a prognosis has limited value and effort should be made to honestly describe the likely 
impact on independence and survival. Specific numbers are best avoided, but explaining that 
dementia overall increases risk of mortality about two-fold can be helpful (with frontotemporal 
dementia having nearly double the risk compared to Alzheimer’s disease, with other subtypes in 
between).10   
 
PROVIDING INFORMATION 
 
The first priority after diagnosis disclosure is provision of relevant information, both verbal and 
written (Figure 1). Planning another face-to-face meeting soon after initial disclosure is good 
practice providing opportunity to repeat information not taken on board initially, to clear up 
misconceptions and to expand on important issues. Care needs to be taken to ensure the person with 
dementia is always at the centre of discussions, as carers can easily become dominant. With patient 
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consent, separate meetings with the family may be helpful to speak more easily about their particular 
concerns such as genetic risk, practising a non-confrontational approach to managing difficult 
behaviours and planning future living arrangements and prognosis.   
 
Directing people to quality information in print or on trustworthy websites will be helpful.  The 
Alzheimer’s Society publish a ‘Dementia Guide’,11 available in multiple formats and languages. 
They also have more detailed factsheets on relevant topics and introductory booklets addressing 
younger onset dementia and each of the less common dementia subtypes. These overcome the 
problem  that much of what is available is generic and ‘alzheimerised’. The Reading Well Books on 
Prescription scheme has 37 recommended books on dementia that are all available to borrow free 
from local libraries. These include not only books giving factual information and advice, but also 
accounts of real life experience of living with dementia that some people will find more illuminating.   
 
For those used to getting their information online, the Dementia Information Service run by NHS 
England provides a weekly email to guide people through the first six weeks after diagnosis. 
Providing addresses of reliable websites will be helpful, together with a general warning about  
shortcomings of health information online. Dementia Talking Point is the Alzheimer’s Society’s 
online community, allowing anyone affected by dementia to join in discussions and to support each 
other. Setting up a private group with other family members and friends can help with engagement 
and ensure everyone is kept in the loop. 
 
Social media encourages peer-based information exchange rather than the traditional expert-led 
model, so providing a more empowered and patient-centred experience.12 Social networking sites 
such as Facebook host local and national dementia support groups and such online forums may be 
especially useful for those with less common dementia subtypes who are always in the minority in 
other settings. Twitter is dominated by links to third party sites, rather than personal anecdotes or 
experiences.13 Instagram may be helpful for people who are best with visual information. Of 
YouTube videos about Alzheimer’s disease, testimonial videos have the highest views suggesting 
that this is preferred rather than a more didactic approach.14 
 
Some general principles of information giving to a newly diagnosed person with dementia and their 
carer are listed in Table 2 and good sources of information in the UK are listed in Table 3. 
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Table 2. NICE guidance15 on information provision to people living with dementia and their 
family members or carers at time of diagnosis.  All information should be relevant to their 
circumstances and the stage of their condition. 
 
Provide oral and written information that explains: 
• what their dementia subtype is and the changes to expect as the condition progresses 
• which health professionals and social care teams will be involved in their care and how to 
contact them 
• if appropriate, how dementia affects driving, and that they need to tell the DVLA and their 
car insurer about their dementia diagnosis 
• their legal rights and responsibilities 
• their right to reasonable adjustments (in line with the Equality Act 2010) if they are working 
or looking for work 
• how local support groups, online forums and national charities, financial and legal advice 
services and advocacy services can help and how to contact them. 
• If it has not been documented earlier, ask the person for their consent for services to share 
information, which people they would like services to share information with (for example 
family members or carers) and what information they would like services to share. Document 
these decisions in the person's records. 
• Direct people and their family members or carers (as appropriate) to relevant services for 
information and support  
• For people who do not want follow-up appointments and who are not using other services, 
ask if they would like to be contacted again at a specified future date. 
• Ensure that people living with dementia and their carers know how to get more information 
and who from if their needs change. 
• Tell people living with dementia (at all stages of the condition) about research studies they 
could participate in. 
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Table 3. Useful sources of information and support for people newly diagnosed with dementia and their carers 
 
National telephone helplines (practical advice and emotional support) 
Alzheimer’s Society (England and Northern Ireland)   0300 222 1122 
Alzheimer Scotland         0808 808 3000 
NHS Direct in Wales         0808 808 2235 
Dementia UK (Admiral Nurses)      0800 888 6678 
 
Support Organisations 
Alzheimer’s Society (England, Wales & Northern Ireland)   www.alzheimers.org.uk 
Alzheimer’s Scotland        www.alzscot.org  
Rare Dementia Support       www.raredementiasupport.org 
The Lewy Body Society       www.lewybody.org 
Carers Trust         www.carers.org 
Carers UK         www.carersuk.org   
Stroke Association        www.stroke.org.uk 
Parkinson’s UK        www.parkinsons.org.uk 
Young Dementia UK         www.youngdementiauk.org 
 
Books  
Books on prescription (including first hand accounts)        www.reading-wel.org.uk/books/books-on-prescription/dementia  
• A Pocket Guide to Understanding Alzheimer's Disease and Other Dementias (2nd edition), by James Warner and Nori Graham. Jessica 
Kingsley Publishers, 2018. 
• Dementia: The One-Stop Guide: Practical advice for families, professionals, and people living with dementia and Alzheimer’s disease, 
by June Andrews. Profile Books Ltd, 2015. 
 
Online dementia education courses  
Dementia Information Service (NHS England)    www.nhs.uk/conditions/dementia/dementia-information-service 
Staying connected and living well      www.futurelearn.com/courses/dementia-care 
Living well as dementia progresses         www.futurelearn.com/courses/comfort-care  
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Driving 
DVLA          www.gov.uk/ dementia-and-driving  
Driving mobility (driving courses and assessments)          www.drivingmobility.org.uk/  
Blue Badge             www.gov.uk/government/publications/blue-badge-can-i-get-one 
 
Benefits and finances 
Department of Work and Pensions       www.dwp.gov.uk 
DirectGov (Benefits and claim forms)      www.gov.uk   
Lasting Power of Attorney        www.lastingpowerofattorney.service.gov.uk 
Money Advice Service       www.moneyadviceservice.org.uk 
Citizens Advice        www.citizensadvice.org.uk 
 
Research 
Join Dementia Research       www.joindementiaresearch.nihr.ac.uk  
Alzheimer’s Research UK       www.alzheimersresearchuk.org 
 
Adaptations, equipment and technology 
Equipment for independent living      https://asksara.dlf.org.uk 
Telecare Services        www.tsa-voice.org.uk/support-at-home 
Assistive technology         www.atdementia.org.uk 
 
Therapeutic activities 
Accessible touchscreen apps for entertainment    www.actodementia.com  
BBC Reminiscence Archive       https://remarc.bbcrewind.co.uk/index.html 
Dementia-friendly arts events and opportunities    www.arts4dementia.org.uk  
Singing for the Brain         www.alzheimers.org.uk/get-support/your-support-services/singing-for-the-brain 
Person-centred activity products      www.active-minds.org/uk/ 
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SOURCES OF FUTURE SUPPORT 
 
The details of a single named contact should be provided at an early stage who will be able to answer 
questions and provide ongoing advice, support and signposting to local services. These people are 
variously termed as dementia navigators, advisers, link workers, key workers or support workers. 
They are most effective when they have a long-term involvement, with regular face to face contact. 
A key role of the care coordinator is to develop a personalised care and support plan. Ideally, they 
should come from a health/clinical background and work as part of a multidisciplinary team.16 In 
Scotland, the government  has guaranteed at least a year’s post-diagnostic support from a named 
individual for everyone diagnosed with dementia.  
Major sources of practical guidance and support are third sector organisations, though availability of 
services differs greatly from area to area. In the UK, the Alzheimer’s Society (and Alzheimer 
Scotland) provide post-diagnostic information and support services for all types of dementia and 
have a comprehensive online directory of regional and local services and activities. These include 
Alzheimer Cafés, Singing for the Brain, Games for the Brain, education programmes, befriending 
and advocacy services, carer support groups and social and activity groups. Their Dementia Connect 
Programme aims to use expert Dementia Advisors to identify individual needs and to help put in 
place personalised support plans to address them. The information and support needs of subtypes of 
dementia are the focus of Rare Dementia Support at the UCL Dementia Research Centre, the Lewy 
Body Society, Parkinson’s UK and the Stroke Association. Younger people with dementia prefer to 
receive support from bespoke services rather than generic provision and specific post-diagnostic 
teams for those of working age are available in some areas. Young Dementia UK and the associated 
Young Dementia Network can provide age-appropriate information and has a prominent role 
nationally in advocating for and supporting younger people with dementia.  
Dementia UK offers help to families living with dementia through contact (by telephone helpline and 
face-to-face) with the Admiral Nurse Service. These specialist dementia nurses help families to 
understand dementia better and to develop the skills needed to effectively manage the condition and 
offer psychological support to family carers.17 Addressing the needs of carers are also the centre of 
attention of Carers UK and the Carers Trust. NICE recommends that carers should be advised about 
their right to a formal assessment of their own needs (known as a ‘Carer’s Assessment’), as well as 
need for short breaks and other respite care.15  They also should be offered specific psychoeducation 
and communication and behavioural management skills training. This should be in a format suitable 
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for them, on an individual basis such as the 8 week manual based START programme,18 or in group 
sessions with other carers, or online. Peer-support groups and networks are also highly valued by 
people with dementia and their carers, particularly by those with rarer subtypes, or onset at a younger 
age. 
 
MEDICATION 
Families often think that drugs are available to ‘treat’ dementia and are eager for an immediate 
prescription. It is wiser to first instigate a thorough medication review, stopping all inappropriate and 
potentially unnecessary drugs, especially those with anticholinergic effects and central nervous 
system depressants such as benzodiazepines and opiates. Whenever possible, dosage regimens 
should be simplified so that all medication can be taken together once daily. This may reduce errors 
more effectively than medication compliance aids such as Dossett boxes and blister packs that are 
widely used, despite little evidence that they improve compliance or safety. They also risk 
engendering a false sense of security amongst carers and prescribers that medication will be taken 
reliably (Figure 2).19 20 
The subtype and severity of dementia will decide whether antidementia drug treatment may be 
suitable. Of the available drugs, NICE guidance15 recommends offering a cholinesterase inhibitor 
(donepezil, rivastigmine or galantamine) as monotherapy in mild or moderate Alzheimer's disease, 
dementia with Lewy bodies or Parkinson’s disease dementia. Memantine should be considered for 
people with moderate Alzheimer's disease or dementia with Lewy bodies and Parkinson’s disease 
dementia if cholinesterase inhibitors are not tolerated or are contraindicated, or if someone presents 
with severe dementia. Memantine also can be added later to established treatment with a 
cholinesterase inhibitor if dementia has progressed to a moderate or severe stage. The drugs should 
only be considered for people with vascular dementia if they have suspected comorbid Alzheimer's 
disease, Parkinson's disease dementia, or dementia with Lewy bodies (mixed dementia).  
 
Checking the pulse rate before initiating cholinesterase inhibitor treatment is appropriate in all 
patients, but a routine ECG is unnecessary unless there is bradycardia or history of unexplained 
syncope.21 Known cardiac contraindications do need to be considered and caution is appropriate 
when people are taking cardiac rate-limiting drugs, such as  beta-blockers, non-dihydropyridine 
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calcium channel blockers, digoxin or amiodarone, when reducing the dose or switching to an 
alternative drug may be an option.   
All the cholinesterase inhibitor drugs have similar efficacy, but donepezil is usually first choice and 
has the advantage of simple dosage regimen. NICE recommends that as long as the recommendation 
to start has been made by a clinician with the necessary knowledge and skills, the first prescription 
may be made in primary care. Everyone needs to understand that benefits are likely to be modest and 
they do not alter the course of the condition, so should not be stopped just because there is no 
improvement or when later dementia severity increases. Details the indications, cautions and 
contraindications for the available antidementia drugs are listed in Table 4.
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Table 4. Indications, cautions and contraindications to available antidementia medication. 
 
 
Drug (dose) 
 
Indications Cautions Contraindications 
Acetylcholinesterase inhibitors (AChEi): 
start at low dose and increase according to 
response and tolerability 
Donepezil (5-10mg od by mouth) 
Galantamine (8-24mg modified 
release od by mouth) 
Rivastigmine (1.5-6mg bd by mouth, 
or 4.6-13.3mg/24h transdermal patch) 
• Mild-moderate Alzheimer’s 
disease 
• Dementia with Lewy bodies 
• Parkinson’s disease dementia 
 
• Pulse 50-60bpm (consider 
ECG) 
• Cardiac rate-limiting drugs 
• COPD or history of asthma 
• Significant GI symptoms 
• Susceptibility to peptic ulcer 
• History of seizures 
• Bladder outflow obstruction 
• Hepatic impairment 
 
• Pulse <50bpm 
• Heart block 
• Sick sinus syndrome 
• QT prolongation 
• Significant airways obstruction 
• Active peptic ulcer 
• Known hypersensitivity 
NMDA antagonist 
Memantine (5-20mg od by mouth – 
titrate up in 5mg steps each week) 
 
• Severe Alzheimer’s disease 
• Moderate Alzheimer’s disease, 
dementia with Lewy bodies, or 
Parkinson’s disease dementia if 
people cannot tolerate, or have 
a contraindication to AChEi 
• Renal impairment (may need 
reduced dose) 
• Severe hepatic impairment 
• Concurrent use of other 
NMDA antagonist 
(amantadine, ketamine, 
dextromethorphan) 
 
• History of seizures 
• Known hypersensitivity 
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People with a vascular or mixed dementia may benefit from aggressive vascular risk factor 
management as recommended for secondary stroke prevention,22 though it should be explained that 
this can only reduce risk of further damage rather than ameliorate established dementia.  In 
frontotemporal dementia, selective serotonin reuptake inhibitors at high dose may help behavioural 
and psychological symptoms - especially disinhibition, irritability and depression - though they have 
no positive effect on cognition.23  
 
No disease modifying treatments have yet been shown to be effective in established dementia, but 
many drugs are in clinical development.24  Whilst interest in experimental treatments for dementia is 
often stimulated by exaggerated media reports, all patients should be encouraged to explore 
opportunities to take part in clinical research. By registering their interest with Join Dementia 
Research,25 people across the UK can be matched with studies open to recruitment, not just of 
pharmacological treatments but also of psychosocial interventions and observational studies. 
 
PRACTICAL INTERVENTIONS IN DAILY LIFE 
 
Discussion about interventions to help manage current and future challenges in day to day life is 
usually welcomed and timely referral to appropriate services, such as occupational therapy or social 
services, will help to keep people living well and should promote autonomy. However, this needs to 
be conducted sensitively, bearing in mind that the person with dementia may not be fully aware of 
the extent of their functional deficits or their implications and family carers may need time to adjust 
to the impact on their own lifestyle and future plans. Ill-timed advice on changes to personal routine 
and advance care planning, or premature referral to other professionals and agencies may merely 
engender resentment, increase patient and carer anxiety, and result in unnecessary dependency. 
Planning ahead is sensible, but for many people with a new dementia diagnosis there is often little 
immediate need or benefit of rushing to make major changes to activities and routines that were in 
place before. It is important to allow time for people to come to terms with the diagnosis and its 
implications and for them not to feel they must tackle everything at once. 
 
Younger people with dementia may still be working at the time of diagnosis and many can continue 
to do so depending on the type of work. Advice about talking to their employer at an early stage is 
appropriate. Sometimes this is a contractual requirement, but it is also necessary if driving is 
involved and it is sensible if there are safety issues or legal or financial responsibilities that need to 
be considered. Seeking advice from a Disability Employment Adviser or involving occupational 
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health or trade union representatives may be helpful. Rather than giving up work, flexible working 
hours or a change of role may be possible, bearing in mind that dementia is classified as a disability 
and therefore employers must make ‘reasonable adjustments’ to accommodate any difficulties. 
Family carers also have the legal right to request flexible working hours to support the person with 
dementia. 
 
People will be keen to keep the brain active. However, whilst crosswords or puzzles such as Sudoku 
may be enjoyable for those used to doing them, it is better to suggest more socially-oriented 
activities if people are wanting to take up something new. Encouraging use of familiar memory aids 
such as making lists, calendars, digital clocks, wipe clean noticeboards and strategically placed 
sticky notes is often helpful (Figure 3). Electronic aids such as smart speakers, locator or prompt 
devices, dementia-specific apps (for both the person with dementia and carers) and other assistive 
technology are playing an increasing role in dementia management.26 There is very limited evidence 
to support the efficacy of formal cognitive training (guided practice on structured tasks to improve or 
maintain particular cognitive abilities).27 Group cognitive stimulation (regularly engaging in a range 
of themed activities and discussions in a social setting) has the most consistent supportive evidence 
and should be offered.28 Group reminiscence (discussion of memories and past experiences using 
prompts to evoke memories and stimulate conversation)29 and individual cognitive 
rehabilitation/reablement (focusing on realistic functional goals tailored to the individual, building 
on strengths and finding ways to compensate for impairments)30 can also be considered.  
 
Any significant sensory deficits should have been identified during diagnostic workup. There is need 
then for good communication with professionals relevant to hearing or vision and prescription of 
corrective devices or other intervention as appropriate.31 32  For those with hearing loss, 
recommending a simple intervention such as ear syringing, or cleaning or servicing hearing aids may 
be all that is necessary to improve hearing and cognitive performance. If problems remain then 
referral to the audiology service is indicated. Those with visual problems, whether due to sight loss 
or perceptual deficits, may benefit from environmental modifications such as strategic use of 
contrasting colours, non-pattern flooring and automatic lighting. Uncorrected refractive errors will 
impair cognitive performance and making sure that the person has clean, up-to-date spectacles and 
uses them consistently is essential. Half of post-refraction visual impairment among people with 
dementia is due to cataracts and expediting surgery may be appropriate.33   
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The benefits of continuing to keep socially active and maintaining leisure interests and hobbies 
should always be emphasised. It will be useful to explain that simplifying activities, decluttering, 
following a routine and minimising distractions are all likely to help performance. It is wise to 
emphasise the value of planning ahead, allowing more time, doing things one at a time and not 
taking it for granted that something will work out just because it has never presented difficulty in the 
past. General advice on maximising physical and cognitive wellbeing by taking regular exercise, not 
smoking, limiting alcohol, maintaining a healthy diet and managing other comorbidities 
appropriately should not be overlooked. 
 
Carers should be alerted to the challenges presented by less familiar environments and change in 
routines and the risk of delirium associated with acute illness or surgery. They should also be made 
aware of ‘John’s Campaign’ (www.johnscampaign.org.uk) to allow family carers of people with 
dementia to stay with them when admitted to hospital and of the Alzheimer’s Society ‘This is me’ 
leaflet (www.alzheimers.org.uk/get-support/publications-factsheets/this-is-me) on which people with 
dementia record details about their likes and dislikes, routines and personal history which can then 
be shared with healthcare staff if they find themselves in an unfamiliar setting.  
 
 
DRIVING 
 
A diagnosis of dementia does not in itself mean that the person is no longer safe to drive. Many 
people with mild dementia are able to continue to drive for the time being, whilst nearly all those 
with more severe dementia are not. Fitness to drive is impaired in non-Alzheimer dementias earlier 
than in Alzheimer’s disease, due to behavioural or motor symptoms increasing risk in addition to 
cognitive factors.34 Any severity of dementia requires that the Driver and Vehicle Licensing Agency 
(DVLA) and vehicle insurance company are informed and it is a professional responsibility that 
clinicians explain this.35  If the person is obviously unfit to drive, they should be told this 
unequivocally and helped to surrender their licence immediately, or the clinician should inform the 
DVLA on their behalf if necessary. In other circumstances, it is best to reflect with the person on the 
benefits and risks of driving and emphasise the legal requirement rather than express a personal 
opinion on their safety, especially as clinicians are generally poor at predicting this. This also helps 
to avoid a difficult conversation deteriorating into an argument that will make it less likely the 
person will accept advice. The risk of withdrawal of the driving licence or likelihood that it will be 
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subject to more frequent review and eventual withdrawal in future should be explained. Whilst the 
person still has a valid licence, a driving assessment at a local centre may help inform the decision. 
  
Losing a driving licence can be a major blow to  self-esteem as well as independence and wellbeing. 
An early discussion of practical alternatives is appropriate (e.g. public transport, taxis, lifts from 
friends) so that usual activities and interests can continue uninterrupted. Recent changes to Blue 
Badge parking regulations in the UK to include people with a ‘hidden disability’ mean that some 
people with more severe dementia may now qualify, helping carers with parking closer to where they 
need to go.  
 
FINANCES, BENEFITS AND LEGAL ISSUES 
 
For many people with dementia and their families there will be concern about finances.36 Younger 
people with dementia in particular may have to consider early retirement and they are more likely to 
have dependent children and other commitments such as a mortgage.  Advice on benefits and help 
with applications is available from Citizens Advice offices or local welfare rights officers. 
Simplifying money management will help to reduce risks. A third-party mandate will allow help 
with banking, but is only valid whilst the person retains capacity to manage the account themselves. 
Direct debits to pay regular bills will ensure they are not overlooked. Paying for things with debit or 
credit cards may be easier using contactless payment, or a chip and signature card that avoids 
problems with remembering PIN numbers. Depending on the severity of dementia and its impact on 
the person’s daily living activities, they may be entitled to the attendance allowance (or personal 
independence payment if under age 65) and may then be disregarded when calculating council tax 
payments if they have ‘severe mental impairment’.  
 
Whilst people still have capacity to do so, they should be encouraged to make a will and a Power of 
Attorney. This can be done through a solicitor, or online. The Alzheimer’s Society also offer a digital 
assistance service to help complete the forms on the person’s behalf. At an early stage it may be 
appropriate to start discussion about other aspects of advance care planning37, such as making an 
advance statement expressing priorities and preferences for the future and an advance decision to 
refuse treatment (advance directive in Scotland and Northern Ireland). Specific help with this are 
available, such as the ‘Planning for your future care’ guide38  and the ‘Coordinate My Care’ service 
(www.coordinatemycare.co.uk) currently available across London. If mental capacity has already 
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been lost by the time of diagnosis, a carer or family member can apply to become a Deputy (or 
equivalent) that may allow them to make certain decisions on the person’s behalf.  
 
CONCLUDING REMARKS 
 
Receiving a dementia diagnosis is life-changing, not just for the person directly affected, but also for 
their family members and others who will be caring for them. They should not be left with 
uncertainty about what the diagnosis means, what interventions will be helpful, and how these can be 
arranged. What they want is: 
 
• Complete information about  the condition, presented in non-technical language. 
• Recognition that the person with dementia and family members may each have differing 
values, priorities and concerns, and their own individual circumstances and needs. 
• Timely advice, treatment and practical support that will keep the person with dementia as 
independent as possible throughout the course of the illness. 
• Someone to talk to who understands their worries and wants, and can put them in touch with 
appropriate help at the time it is needed in the future. 
 
Those responsible for assessment and diagnosis must therefore put as much time and effort into what 
happens next, telling the diagnosis sensitively but clearly, engaging patients and family in all 
decisions, and ensuring planned follow up meets individual needs. 
 
 
 
KEY POINTS 
 
• Most people with dementia want to be told their diagnosis, using non-technical language and 
avoiding euphemisms. 
• The person with dementia should not be excluded from discussions and carers should not 
dominate the consultation or take over. Both will have needs that should be addressed. 
• Verbal information needs to be supplemented by good quality written information, in print or 
on trustworthy websites. 
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• Interventions should be individualised, appropriate to the stage and subtype of dementia and 
tailored to each patient’s and carer’s needs and priorities. 
• Details of a single named contact should be given after diagnosis, to answer questions and 
provide ongoing advice, support and signposting to local services. 
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FIGURE LEGENDS 
 
 
 
Figure 1.  Relevant written information should be readily available in clinic areas   
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Figure 2.  Medication compliance aids may highlight non-adherence to drug regimens rather than 
ensure adherence.  
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Figure 3.  Simple memory aids in everyday life – a digital clock, shopping list on a smartphone, 
sticky pad message, magnetic timer alarm 
 
 
 
 
 
